Parathyroid autotransplantation
Conditions
Interventions
Observation group (Experiment one):None
In situ preservation group (Experiment two):In situ parathyroid gland preservation (without autologous parathyroid transplantation)
Parathyroid sternocleidomastoid muscle transplantation group (Experiment two):Selection of surgical methods for parathyroid autotransplantation (sternocleidomastoid muscle transplantation)
Forearm brachioradial autologous parathyroid transplantation group (Experiment two):Selection of surgical methods for parathyroid autotransplantation (brachioradialis forearm muscle transplantation)
25 hydroxy-VD3 supplement group (Experiment three):None
25 hydroxy-VD3 unsupplemented group (Experiment three):None
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The patient and his family members were aware of the study and signed the consent form; 2. Serum PTH and Ca2+ concentrations were at normal levels before operation; 3. Patients with at least unilateral thyroidectomy; 4. The patient had no history of head and neck surgery or radiotherapy. 5. On the first day after surgery, serum PTH was lower than the lower limit of normal and was included in Experiment Three.
Exclusion criteria
Exclusion criteria: 1. Patients with organ dysfunction or inability to tolerate surgery; 2. Patients with recurrence of central lymph nodes after operation; 3. Patients who could not complete the review on time during the follow-up; 4. Patients requiring postoperative radioiodine therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum calcium ion;Serum parathyroid hormone;25 hydroxyvitamin D;IL-1ß;IL-6;TNF-a;CRP; | — |
Countries
China
Contacts
Public ContactShi Chen-lei
The Second Affiliated Hospital of Harbin Medical University
Outcome results
None listed